
Translating Rare Kidney Cancer Research into Clinical Trials
At the 2025 Kidney Cancer Research Summit, A. Ari Hakimi, MD, moderated a session titled “Biology and Therapeutic Vulnerabilities: Needs and Opportunities,” where doctors presented on different variants of kidney cancer, such as papillary, chromophobe, …